Voyager Therapeutics Beats Expectations in Q3
Update: 2025-11-10
Description
Voyager Therapeutics surpasses Wall Street expectations with Q3 results: Despite a net loss of $27.9 million, the gene therapy company reports stronger-than-anticipated revenue of $13.4 million.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
